Synthesis and pharmacological activity of diarylindole derivatives. Cytotoxic agents based on combretastatins

Bioorganic and Medicinal Chemistry Letters

Volumn 9, Issue 16, 1999, Pages 2303-2308

  Medarde, Manuel ^a   Ramos, Angel C ^a   Caballero, Esther ^a   Peláez Lamamié de Clairac, Rafael ^a   López, Jose Luis ^a   Grávalos, Dolores G ^b   San Feliciano, Arturo ^a  

^a Camp miguel U   (Spain)

^b PHARMAMAR S A   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

COMBRETASTATIN; COMBRETASTATIN DERIVATIVE; CYTOTOXIC AGENT; INDOLE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; DRUG ACTIVITY; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; HUMAN CELL;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; BIBENZYLS; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; STILBENES; TUMOR CELLS, CULTURED;

EID: 0033575722     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(99)00370-4     Document Type: Article

References (36)

1. Pettit, G.R.; Cragg, G.M.; Herald, D.L.; Schmidt, J.M.; Lohavanijaya, P. Can. J. Chem. 1982, 60, 1374-1376. Pettit, G.R.; Singh, B.S. Can. J. Chem. 1987, 65, 2390-2396. Pettit, G.R.; Singh, B.S.; Niven, M.L.; Hamel, E.; Schmidt, J.M. J. Nat. Prod. 1987, 50, 119-131. Pettit, G.R.; Cragg, G.M.; Singh, S.B. J. Nat. Prod. 1987, 50, 386-391. Pettit, G.R.; Singh, B.S.; Schmidt, J.M.; Niven, M.L.; Hamel, E.; Lin, Ch.M. J. Nat. Prod. 1988, 51, 517-527. Pettit, G.R.; Singh, S.B.; Hamel, E.; Lin, Ch.M.; Alberts, D.S.; Garcia-Kendall, D. Experientia1989, 45, 209-211.
2. Pettit, G.R.; Cragg, G.M.; Herald, D.L.; Schmidt, J.M.; Lohavanijaya, P. Can. J. Chem. 1982, 60, 1374-1376. Pettit, G.R.; Singh, B.S. Can. J. Chem. 1987, 65, 2390-2396. Pettit, G.R.; Singh, B.S.; Niven, M.L.; Hamel, E.; Schmidt, J.M. J. Nat. Prod. 1987, 50, 119-131. Pettit, G.R.; Cragg, G.M.; Singh, S.B. J. Nat. Prod. 1987, 50, 386-391. Pettit, G.R.; Singh, B.S.; Schmidt, J.M.; Niven, M.L.; Hamel, E.; Lin, Ch.M. J. Nat. Prod. 1988, 51, 517-527. Pettit, G.R.; Singh, S.B.; Hamel, E.; Lin, Ch.M.; Alberts, D.S.; Garcia-Kendall, D. Experientia1989, 45, 209-211.
3. Pettit, G.R.; Cragg, G.M.; Herald, D.L.; Schmidt, J.M.; Lohavanijaya, P. Can. J. Chem. 1982, 60, 1374-1376. Pettit, G.R.; Singh, B.S. Can. J. Chem. 1987, 65, 2390-2396. Pettit, G.R.; Singh, B.S.; Niven, M.L.; Hamel, E.; Schmidt, J.M. J. Nat. Prod. 1987, 50, 119-131. Pettit, G.R.; Cragg, G.M.; Singh, S.B. J. Nat. Prod. 1987, 50, 386-391. Pettit, G.R.; Singh, B.S.; Schmidt, J.M.; Niven, M.L.; Hamel, E.; Lin, Ch.M. J. Nat. Prod. 1988, 51, 517-527. Pettit, G.R.; Singh, S.B.; Hamel, E.; Lin, Ch.M.; Alberts, D.S.; Garcia-Kendall, D. Experientia1989, 45, 209-211.
4. Pettit, G.R.; Cragg, G.M.; Herald, D.L.; Schmidt, J.M.; Lohavanijaya, P. Can. J. Chem. 1982, 60, 1374-1376. Pettit, G.R.; Singh, B.S. Can. J. Chem. 1987, 65, 2390-2396. Pettit, G.R.; Singh, B.S.; Niven, M.L.; Hamel, E.; Schmidt, J.M. J. Nat. Prod. 1987, 50, 119-131. Pettit, G.R.; Cragg, G.M.; Singh, S.B. J. Nat. Prod. 1987, 50, 386-391. Pettit, G.R.; Singh, B.S.; Schmidt, J.M.; Niven, M.L.; Hamel, E.; Lin, Ch.M. J. Nat. Prod. 1988, 51, 517-527. Pettit, G.R.; Singh, S.B.; Hamel, E.; Lin, Ch.M.; Alberts, D.S.; Garcia-Kendall, D. Experientia1989, 45, 209-211.
5. Pettit, G.R.; Cragg, G.M.; Herald, D.L.; Schmidt, J.M.; Lohavanijaya, P. Can. J. Chem. 1982, 60, 1374-1376. Pettit, G.R.; Singh, B.S. Can. J. Chem. 1987, 65, 2390-2396. Pettit, G.R.; Singh, B.S.; Niven, M.L.; Hamel, E.; Schmidt, J.M. J. Nat. Prod. 1987, 50, 119-131. Pettit, G.R.; Cragg, G.M.; Singh, S.B. J. Nat. Prod. 1987, 50, 386-391. Pettit, G.R.; Singh, B.S.; Schmidt, J.M.; Niven, M.L.; Hamel, E.; Lin, Ch.M. J. Nat. Prod. 1988, 51, 517-527. Pettit, G.R.; Singh, S.B.; Hamel, E.; Lin, Ch.M.; Alberts, D.S.; Garcia-Kendall, D. Experientia1989, 45, 209-211.
6. Pettit, G.R.; Cragg, G.M.; Herald, D.L.; Schmidt, J.M.; Lohavanijaya, P. Can. J. Chem. 1982, 60, 1374-1376. Pettit, G.R.; Singh, B.S. Can. J. Chem. 1987, 65, 2390-2396. Pettit, G.R.; Singh, B.S.; Niven, M.L.; Hamel, E.; Schmidt, J.M. J. Nat. Prod. 1987, 50, 119-131. Pettit, G.R.; Cragg, G.M.; Singh, S.B. J. Nat. Prod. 1987, 50, 386-391. Pettit, G.R.; Singh, B.S.; Schmidt, J.M.; Niven, M.L.; Hamel, E.; Lin, Ch.M. J. Nat. Prod. 1988, 51, 517-527. Pettit, G.R.; Singh, S.B.; Hamel, E.; Lin, Ch.M.; Alberts, D.S.; Garcia-Kendall, D. Experientia 1989, 45, 209-211.
7. Lin, Ch.M.; Singh, S.B.; Chu, P.S.; Dempcey, R.O.; Schmidt, J.M.; Pettit, G.R.; Hamel, E. Mol. Pharmacol. 1988, 34, 200-208. Cushman, M.; Nagarathnam, D.; Gopal, D.; He, H.M.; Lin, Ch.M.; Hamel, E. J. Med. Chem. 1992, 35, 2293-2306.
8. Lin, Ch.M.; Singh, S.B.; Chu, P.S.; Dempcey, R.O.; Schmidt, J.M.; Pettit, G.R.; Hamel, E. Mol. Pharmacol.1988, 34, 200-208. Cushman, M.; Nagarathnam, D.; Gopal, D.; He, H.M.; Lin, Ch.M.; Hamel, E. J. Med. Chem. 1992, 35, 2293-2306.
9. Getahun, Z.; Jurd, L.; Chu, P.S.; Lin, Ch.M.; Hamel, E. J. Med. Chem. 1992, 35, 1058-1067. Cushman, M.;Nagarathnam, D.; Gopal, D.; He, H-M.; Lin, Ch.M.; Hamel, E. J. Med. Chem. 1992, 35, 2293-2306.
10. Getahun, Z.; Jurd, L.; Chu, P.S.; Lin, Ch.M.; Hamel, E. J. Med. Chem. 1992, 35, 1058-1067. Cushman, M.; Nagarathnam, D.; Gopal, D.; He, H-M.; Lin, Ch.M.; Hamel, E. J. Med. Chem. 1992, 35, 2293-2306.
11. Cushman, M.; Nagarathnam, D.; Gopal, D.; Chakraborti, A.K.; Lin, Ch.M.; Hamel, E. J. Med. Chem. 1991, 34, 2579-2588.
12. Dark, G.G.; Hill, S.A.; Prise, V.E.; Toze, G.M.; Pettit, G.R.; Chaplin, D.J. Cancer Res. 1997, 57, 1829-1834.
13. Jardine, I. "Podophyllotoxins" in "Anticancer Agents Based on Natural Products Models" Casady, J.M.; Douros, J. Ed.; Academic Press: New York, 1980; 319-351. Ayres, D.C.; Loike, J.D. "Lignans. Chemical, Biological and Clinical Properties" Chap. 3. Cambridge University Press, Cambridge, U.K. 1990.
14. Jardine, I. "Podophyllotoxins" in "Anticancer Agents Based on Natural Products Models" Casady, J.M.;Douros, J. Ed.; Academic Press: New York, 1980; 319-351. Ayres, D.C.; Loike, J.D. "Lignans. Chemical, Biological and Clinical Properties" Chap. 3. Cambridge University Press, Cambridge, U.K. 1990.
15. Capraro, H.G.; Brossi, A. "Tropolonic Colchicum alkaloids" in "The Alkaloids" Vol. 23. Brossi, A. Ed.; Academic Press, New York, 1984; 1-70. Boye, O..; Brossi, A. "The Alkaloids" Vol. 41. Brossi, A. Ed.;Academic Press, New York, 1992; 125-150. Muzaffar, A.; Brossi, A.; Lin, C.M.; Hamel, E. J. Med. Chem.1990, 33, 567-571.
16. Capraro, H.G.; Brossi, A. "Tropolonic Colchicum alkaloids" in "The Alkaloids" Vol. 23. Brossi, A. Ed.;Academic Press, New York, 1984; 1-70. Boye, O..; Brossi, A. "The Alkaloids" Vol. 41. Brossi, A. Ed.; Academic Press, New York, 1992; 125-150. Muzaffar, A.; Brossi, A.; Lin, C.M.; Hamel, E. J. Med. Chem.1990, 33, 567-571.
17. Capraro, H.G.; Brossi, A. "Tropolonic Colchicum alkaloids" in "The Alkaloids" Vol. 23. Brossi, A. Ed.;Academic Press, New York, 1984; 1-70. Boye, O..; Brossi, A. "The Alkaloids" Vol. 41. Brossi, A. Ed.;Academic Press, New York, 1992; 125-150. Muzaffar, A.; Brossi, A.; Lin, C.M.; Hamel, E. J. Med. Chem. 1990, 33, 567-571.
18. Shirai, R.; Tokuda, K.; Koiso, Y.; Iwasaki, S. Bioorg. Med. Chem. Lett. 1994, 4, 699-704.
19. Cushman, M.; He, H.H.; Lin, Ch.M.; Hamel, E. J. Med. Chem. 1993, 36, 2817-2821.
20. Denyer, C.V.; Reddy, M.T.; Jenkins, D.C.; Rapson, E.;Watts, S.D.M. Arch. Pharm. (Weinheim) 1994, 327, 95-98.
21. Kuo, S.C.; Lee, H.Z.; Juang, J.P.; Lin, Y.T.; Wu, T.S.; Chang, J.J.; Lednicer, D.; Paull, K.D.; Lin, M.C.; Hamel, E.; Lee, K.H. J. Med. Chem. 1993, 36, 1146-1156. Li, L.; Wang, H.K.; Kuo, S.Ch.; Wu, T.S.;Mauger, A.; Lin, Ch.M.; Hamel, E.; Lee, K.H. J. Med. Chem. 1994, 37, 3400-3407.
22. Kuo, S.C.; Lee, H.Z.; Juang, J.P.; Lin, Y.T.; Wu, T.S.; Chang, J.J.; Lednicer, D.; Paull, K.D.; Lin, M.C.;Hamel, E.; Lee, K.H. J. Med. Chem. 1993, 36, 1146-1156. Li, L.; Wang, H.K.; Kuo, S.Ch.; Wu, T.S.; Mauger, A.; Lin, Ch.M.; Hamel, E.; Lee, K.H. J. Med. Chem. 1994, 37, 3400-3407.
23. a D.G.; San Feliciano, A. Bioorg. Med. Chem. Lett. 1995, 5, 229-232.
24. Nandy, P.; Banerjee, S.; Gao, H.; Hui, M.B.V.; Lien, E.J. Pharm. Research. 1991, 8, 776-781.
25. Medarde, M.; Peláez-Lamamié de Clairac, R.; López, J.L.; San Feliciano, A. J. Nat. Products 1994, 57, 1136-1144.
26. Ramos, A.C. Ph.D. dissertation. University of Salamanca, June 1997. Caballero, E.; Medarde, M.; Ramos, A.C.; Peláez, R.; Rey, B., San Feliciano, A. XVth EFMC International Symposium on Medicinal Chemistry. Book of Abstracts p. 115. Edinburgh, 1998.
27. Haar, E.; Rosenkranz, H.S.; Hamel, E.; Day, B.W. Bioorg. Med. Chem. 1996, 4, 1659-1671.
28. Shirai, R.; Takayama, H.; Nishikawa, A.; Koiso, Y.; Hashimoto, Y. Bioorg. Med. Chem. Lett. 1998, 8, 1997-2000.
29. Ohsumi, K.; Hatanaka, T.; Fujita, K.; Nakagawa, R.; Fukuda, Y.; Nihei, Y.; Suga, Y.; Morinaga, Y.; Akiyama, Y.; Tsuji, T. Bioorg. Med. Chem. Lett. 1998, 8, 3153-3158. Shirai, R.; Ukabe, T.; Iwasaki, S.Heterocycles 1997, 46, 1457-1466.
30. Ohsumi, K.; Hatanaka, T.; Fujita, K.; Nakagawa, R.; Fukuda, Y.; Nihei, Y.; Suga, Y.; Morinaga, Y.;Akiyama, Y.; Tsuji, T. Bioorg. Med. Chem. Lett. 1998, 8, 3153-3158. Shirai, R.; Ukabe, T.; Iwasaki, S. Heterocycles 1997, 46, 1457-1466.
31. 13C-NMR) are consistent with proposed structures 4a-e. Purity of all tested compounds is higher than 95%.
32. San Feliciano, A.; Medarde, M.; Pelaez Lamamié de Clairac, R.; García, M.D.; Ruiz, P.; García de Quesada, M.T Arch. Pharm. (Weinheim) 1993, 326, 421-426.
33. 50 for compounds displaying low inhibition of cell growth at the assayed concentrations were not determined and are indicated 〉(highest tested concentration).
34. Shi, Q.; Chen, K.; Morris-Natschke, S.L.; Lee, K-H. Current Pharm. Design 1998, 4, 219-248.
35. 10 GI50 = Log concentrations which reduced cell growth to 50% of level at the onset of the experiment. Log10 LC50 = Log concentrations which reduces the number of cells to 50% at the start of the experiment. Grever, M.R.; Schepartz, S.A.; Chabner, B.A. Seminars Oncol. 1992, 19, 622-638. Monks, A.; Scudiero, D.;Skehan, P.; Shoemaker, R.; Paull, K.; Vistica, D.; Hose, C.; Langley, J.; Cronise, P., Vaigro-Wolff, A.; Gray-Goodrich, M.; Campbell, H.; Mayo, J. and Boyd, M. J. Natl. Cancer Inst. 1991, 83, 757-766.
36. 10 GI50 = Log concentrations which reduced cell growth to 50% of level at the onset of the experiment.Log10 LC50 = Log concentrations which reduces the number of cells to 50% at the start of the experiment.Grever, M.R.; Schepartz, S.A.; Chabner, B.A. Seminars Oncol. 1992, 19, 622-638. Monks, A.; Scudiero, D.; Skehan, P.; Shoemaker, R.; Paull, K.; Vistica, D.; Hose, C.; Langley, J.; Cronise, P., Vaigro-Wolff, A.; Gray-Goodrich, M.; Campbell, H.; Mayo, J. and Boyd, M. J. Natl. Cancer Inst. 1991, 83, 757-766.